Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Free Radical Biology & Medicine

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.freeradbiomed.2010.05.005PMID 20471471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

  2010cited by this paper
• RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction

  2009cited by this paper
• Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer’s disease

  2009cited by this paper
• Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells

  2009cited by this paper
• Upregulation of RAGE at the blood‐brain barrier in streptozotocin‐induced diabetic mice

  2009cited by this paper
• Diabetes impairs hippocampal function via advanced glycation end product mediated new neuron generation in animals with diabetes-related depression.

  2009cited by this paper
• Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

  2008cited by this paper
• Differentiation Increases the Resistance of Neuronal Cells to Amyloid Toxicity

  2008cited by this paper
• Cytotoxicity of Aβ 1-42, RAGE23-54, and An Aβ -RAGE Complex in PC-12 Cells

  2007cited by this paper
• PKC delta and NADPH oxidase in AGE-induced neuronal death.

  2007cited by this paper
• Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells.

  2007cited by this paper
• Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.

  2007cited by this paper
• Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

  2007cited by this paper
• Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease.

  2007cited by this paper
• Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells--protection by carbonyl scavengers.

  2007cited by this paper
• The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo.

  2007cited by this paper
• Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

  2007cited by this paper
• RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

  2006cited by this paper
• The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.

  2006cited by this paper
• Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer’s Disease

  2006cited by this paper
• The induction of surface β-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products

  2006cited by this paper
• Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.

  2005cited by this paper
• The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease.

  2004cited by this paper
• Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

  2004cited by this paper
• Glyceraldehyde-derived advanced glycation end products in Alzheimer’s disease

  2004cited by this paper
• Increased risk of type 2 diabetes in Alzheimer disease.

  2004cited by this paper
• Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

  2004cited by this paper
• Differential effects of “Advanced glycation endproducts” and β-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y

  2004cited by this paper
• Advanced glycation endproduct precursor alters intracellular amyloid- β/AβPP carboxy-terminal fragment aggregation and cytotoxicity

  2004cited by this paper
• RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier

  2004cited by this paper
• Protective Effect of the Xanthate, D609, on Alzheimer's Amyloid β-peptide (1–42)-induced Oxidative Stress in Primary Neuronal Cells

  2004cited by this paper
• Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

  2004cited by this paper
• Nϵ-Carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease

  2004cited by this paper
• Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease.

  2004cited by this paper
• N-Acetyl-L-Cystein downregulates β-amyloid precursor protein gene transcription in human neuroblastoma cells

  2004cited by this paper
• N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.

  2004cited by this paper
• Increased expression of amyloid precursor protein in oral squamous cell carcinoma

  2004cited by this paper
• Effect of β-amyloid on endothelial cells: lack of direct toxicity, enhancement of MTT-induced cell death and intracellular accumulation

  2003cited by this paper
• Advanced glycation endproducts and pro‐inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology

  2003cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract.

  2003cited by this paper
• β‐Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon ‐γ and ‘advanced glycation endproducts’ in a murine microglia cell line

  2003cited by this paper
• Intraneuronal advanced glycation endproducts in presenilin‐1 Alzheimer's disease

  2002cited by this paper
• Differential effects of "advanced glycation endproducts" and ??-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y

  2002cited by this paper
• Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

  2002cited by this paper
• Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line.

  2002cited by this paper
• Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease

  2001cited by this paper
• Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.

  2001cited by this paper
• Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.

  2001cited by this paper
• N‐Acetyl‐l‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001cited by this paper
• N-Acetyl-L-Cystein downregulates beta-amyloid precursor protein gene transcription in human neuroblastoma cells.

  2001cited by this paper
• Protein „AGEing”– cytotoxicity of a glycated protein increases with its degree of AGE-modification

  2001cited by this paper
• Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

  2001cited by this paper
• Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism.

  2001cited by this paper
• Induction of cytokines in glial cells surrounding cortical β‐amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

  2000cited by this paper
• Mercury Induces Cell Cytotoxicity and Oxidative Stress and Increases β‐Amyloid Secretion and Tau Phosphorylation in SHSY5Y Neuroblastoma Cells

  2000cited by this paper
• Neurotoxicity of Advanced Glycation End‐Products for Cultured Cortical Neurons

  2000cited by this paper
• Advanced Glycation Endproducts

  1999cited by this paper
• Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice.

  1999cited by this paper
• Investigations on oxidative stress and therapeutical implications in dementia

  1999cited by this paper
• Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

  1998cited by this paper
• Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease.

  1998cited by this paper
• Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.

  1998cited by this paper
• Plasma protein glycation in Alzheimer's disease

  1998cited by this paper
• Aging, metabolism, and Alzheimer disease: review and hypotheses.

  1997cited by this paper
• Advanced glycation endproducts in ageing and Alzheimer's disease.

  1997cited by this paper
• Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide.

  1997cited by this paper
• Exploring the etiology of Alzheimer disease using molecular genetics.

  1997cited by this paper
• The Pathogenesis of Senile Plaques

  1997cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging

  1996cited by this paper
• Analysis of microtubule-associated protein tau glycation in paired helical filaments.

  1994cited by this paper
• Advanced Maillard reaction end products are associated with Alzheimer disease pathology

  1994cited by this paper
• Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.

  1994cited by this paper
• Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

  1994cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994cited by this paper
• Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging.

  1994cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress.

  1992cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4(695) mRNA is predominantly produced in rat and human brain.

  1990cited by this paper
• Alzheimerʼs disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1988cited by this paper
• Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

  1988cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper

• RAGE-Mediated Effects of Formaldehyde in Alzheimer’s Disease

  2025cites this paper
• Methylglyoxal, a Knot to Be Untied in Brain Glucose Hypometabolism

  2025cites this paper
• 1275‐nm Photobiomodulation Alleviates Brain Drainage Impairment as a Promising Therapeutic Strategy for Aging‐Related Neurological Decline

  2025cites this paper
• The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication

  2025cites this paper
• Advanced glycation end products and human diseases

  2025cites this paper
• Moringa oleifera Extracts as Strategic Phyto‐Therapy for Alzheimer's Disease

  2025cites this paper
• Effect of advanced glycation end-products in a wide range of medical problems including COVID-19.

  2024cites this paper
• The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification.

  2024cites this paper
• Mechanisms Underlying Obesity-induced Aβ Accumulation in Alzheimer's Disease: A Qualitative Review.

  2024cites this paper
• Advanced Glycation End Products in Neurodegenerative Diseases

  2024cites this paper
• Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-β.

  2023cites this paper
• Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer’s Disease

  2023cites this paper
• Abelmoschus eculentus Seed Extract Exhibits In Vitro and In Vivo Anti-Alzheimer’s Potential Supported by Metabolomic and Computational Investigation

  2023cites this paper
• AGE RAGE Pathways: Cardiovascular Disease and Oxidative Stress

  2023cites this paper
• Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer’s disease and cardiovascular diseases

  2023cites this paper
• Mori Cortex radicis extract protected against diet-induced neuronal damage by suppressing the AGE-RAGE/MAPK signaling pathway in C. elegans and mouse model

  2022cites this paper
• In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration

  2022cites this paper
• A new K+channel-independent mechanism is involved in the antioxidant effect of XE-991 in an in vitro model of glucose metabolism impairment: implications for Alzheimer’s disease

  2022influential citation
• AGEs RAGE Pathways: Alzheimer’s Disease

  2022cites this paper
• Understanding the role of glycation in the pathology of various non-communicable diseases along with novel therapeutic strategies.

  2022cites this paper
• p-Coumaric acid protects against D-galactose induced neurotoxicity by attenuating neuroinflammation and apoptosis in mice brain

  2022cites this paper
• The Hidden Notes of Redox Balance in Neurodegenerative Diseases

  2022cites this paper
• 1,8-Cineole Ameliorates Advanced Glycation End Products-Induced Alzheimer’s Disease-like Pathology In Vitro and In Vivo

  2022cites this paper
• Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease

  2021cites this paper
• The Neuroprotective Effect of L-Carnitine against Glyceraldehyde-Induced Metabolic Impairment: Possible Implications in Alzheimer’s Disease

  2021cites this paper
• Aminoguanidine ameliorates ovariectomy-induced neuronal deficits in rats by inhibiting AGE-mediated Aβ production.

  2021cites this paper
• The role of type 2 Diabetes mellitus as a risk factor for Alzheimer's and Parkinson's diseases

  2021cites this paper
• NCX1 and EAAC1 transporters are involved in the protective action of glutamate in an in vitro Alzheimer's disease-like model.

  2020cites this paper
• Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System

  2020cites this paper
• CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers

  2020cites this paper
• Therapeutic potential of carnosine and its derivatives in the treatment of human diseases.

  2020cites this paper
• Hypoxia-Induced Degenerative Protein Modifications Associated with Aging and Age-Associated Disorders

  2020cites this paper
• Amyloid protein aggregation in diabetes mellitus accelerate intervertebral disc degeneration.

  2020cites this paper
• Role of Advanced Glycated End Products (AGEs) in Predicting Diabetic Complications Using Machine Learning Tools: A Review from Biological Perspective

  2020cites this paper
• SQSTM1/ p62 oligomerization contributes to Aβ-induced inhibition of Nrf2 signaling.

  2020cites this paper
• Spinosin Inhibits Aβ1-42 Production and Aggregation via Activating Nrf2/HO-1 Pathway

  2019cites this paper
• Oral administration of green tea Epigallocatechin-3-gallate reduces oxidative stress and enhances restoration of cardiac function in diabetic rats receiving autologous transplantation of adipose-derived stem cells

  2019cites this paper
• Nonenzymatic Posttranslational Protein Modifications: Mechanism and Associated Disease Pathologies

  2019cites this paper
• Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention

  2019cites this paper
• The amyloid precursor protein (APP) processing as a biological link between Alzheimer's disease and cancer.

  2019cites this paper
• Dicarbonyl Stress at the Crossroads of Healthy and Unhealthy Aging

  2019cites this paper
• Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

  2018cites this paper
• Autophagy plays a protective role in advanced glycation end products- induced apoptosis of chondrocytes via regulation of tumor necrosis factor-α , nuclear factor-κ B and reactive oxygen species

  2018cites this paper
• Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions

  2018cites this paper
• Evidence for altered insulin receptor signaling in Alzheimer's disease

  2018cites this paper
• The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.

  2018cites this paper
• The Role of Free Radicals in Autophagy Regulation: Implications for Ageing

  2018cites this paper
• Involvement of calpain in the neuropathogenesis of Alzheimer’s disease

  2018cites this paper
• Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease

  2017cites this paper
• Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease

  2017cites this paper
• Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells

  2017cites this paper
• Similarities and interactions between the ageing process and high chronic intake of added sugars

  2017cites this paper
• Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf2 regulation in vitro

  2017cites this paper
• Structures and interactions of amyloidogenic polypeptides in biomimetic environments.

  2017cites this paper
• Relação entre a formação de radicais livres e a doença de alzheimer: revisão sistemática

  2017cites this paper
• Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitro.

  2017cites this paper
• Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease

  2017cites this paper
• Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus

  2016cites this paper
• Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation

  2016cites this paper
• Glycation in Parkinson's disease and Alzheimer's disease

  2016cites this paper
• Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis.

  2016cites this paper
• PSEUDOAFFINITY CHROMATOGRAPHY ENRICHMENT OF GLYCATED PEPTIDES FOR MONITORING ADVANCED GLYCATION END PRODUCTS (AGES) IN METABOLIC DISORDERS

  2016cites this paper
• Estudio in vitro de la capacidad antiglicante y mecanismo de acción de subproductos agroalimentarios. Obtención de un extracto vegetal antiglicante y su evaluación en una matriz alimentaria y modelo celular

  2016cites this paper
• Perindopril Attenuates Lipopolysaccharide-Induced Amyloidogenesis and Memory Impairment by Suppression of Oxidative Stress and RAGE Activation.

  2016cites this paper
• The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease

  2015influential citation
• Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5.

  2015cites this paper
• Suppression of antioxidant Nrf-2 and downstream pathway in H9c2 cells by advanced glycation end products (AGEs) via ERK phosphorylation.

  2015cites this paper
• Comparison of molecular functions of lactoferrin and amyloid precursor protein support their functional roles in the innate immune system and links with infection in Alzheimer’s disease risk.

  2015cites this paper
• Impact d'un régime riche en saccharose sur la sarcopénie chez le rat âgé ; Conséqences métaboliques au niveau hépatique et cérébral. Effets préventifs d'un mélange de micronutriments. Spécialité

  2015cites this paper
• Glucagon-like peptide-1 regulates mitochondrial biogenesis and tau phosphorylation against advanced glycation end product-induced neuronal insult: Studies in vivo and in vitro.

  2015cites this paper
• Amnestic Mild Cognitive Impairment and Conversion to Alzheimer's Disease: Insulin Resistance and Glycoxidation as Early Biomarker Clusters

  2015cites this paper
• Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.

  2014cites this paper
• Role of Methylglyoxal in Alzheimer's Disease

  2014cites this paper
• The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach

  2014cites this paper
• Reprint of "accumulation of modified proteins and aggregate formation in aging".

  2014cites this paper
• α-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction.

  2014cites this paper
• Accumulation of modified proteins and aggregate formation in aging.

  2014cites this paper
• Cell Migration Is Regulated by AGE-RAGE Interaction in Human Oral Cancer Cells In Vitro

  2014cites this paper
• Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans

  2014cites this paper
• Radix Achyranthis Bidentatae improves learning and memory capabilities in ovariectomized rats

  2013cites this paper
• ASSESSMENT OF PATHOPHYSIOLOGICAL MECHANISMS IN ETIOPATHOGENY OF CHRONIC AND AGGRESSIVE PERIODONTAL DISEASE DOCTORATE THESIS - Abstract -

  2013cites this paper
• Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated wistar rats.

  2013cites this paper
• Dimerumic acid attenuates receptor for advanced glycation endproducts signal to inhibit inflammation and diabetes mediated by Nrf2 activation and promotes methylglyoxal metabolism into d-lactic acid.

  2013cites this paper
• The Janus Face of PAMAM Dendrimers Used to Potentially Cure Nonenzymatic Modifications of Biomacromolecules in Metabolic Disorders—A Critical Review of the Pros and Cons

  2013cites this paper
• Cell Hypertrophy and MEK/ERK Phosphorylation are Regulated by Glyceraldehyde-Derived AGEs in Cardiomyocyte H9c2 Cells

  2013cites this paper
• Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective.

  2012cites this paper
• Effect of germination on total phenolic compounds, total antioxidant capacity, Maillard reaction products and oxidative stress markers in canihua (Chenopodium pallidicaule)

  2012cites this paper
• Anti-Amyloidogenic Effect of Thiacremonone through Anti-Inflamation In Vitro and In Vivo Models

  2012cites this paper
• BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease

  2012cites this paper
• Potential of a γ-glutamyl-transpeptidase-stable glutathione analogue against amyloid-β toxicity.

  2012cites this paper
• Hydrogen peroxide induces neurite degeneration: Prevention by tocotrienols

  2011cites this paper
• Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases

  2011cites this paper
• Beneficial Effect of Traditional Chinese Medicinal Formula Danggui-Shaoyao-San on Advanced Glycation End-Product-Mediated Renal Injury in Streptozotocin-Diabetic Rats

  2011cites this paper
• Advanced glycation end products overload might explain intracellular cobalamin deficiency in renal dysfunction, diabetes and aging.

  2011cites this paper
• Investigation of anti-inflammatory compounds from food and plant libraries for use in Alzheimer's disease

  2011cites this paper
• Role of Advanced Glycation on Aggregation and DNA Binding Properties of α-Synuclein

  2011cites this paper
• s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose.

  2011cites this paper
• Photonic homeostatics

  2010influential citation